Corporate calendar for Repligen Corporation (RGEN): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-11-03 | $0.46 | $207M |
| 2026-07-28 | $0.45 | $202M |
| 2026-05-05 | $0.38 | $192M |
| 2026-02-24 | $0.44 | $193M |
| 2025-10-28 | $0.42 | $182M |
| 2025-07-29 | $0.40 | $175M |
| 2025-04-29 | $0.35 | $164M |
Price
| Price | $189.50 |
| Market Cap | $10.7B |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 1 |
| Buy | 21 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 24 |
| Avg rating (1-5) | 0.96 |
Related companies: ATR · AVTR · BAX · BIO · CRL · DVA · GMED
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of RGEN: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks